739 related articles for article (PubMed ID: 34497604)
21. Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.
He J; Huang F; Zhang J; Chen Q; Zheng Z; Zhou Q; Chen D; Li J; Chen J
J Med Virol; 2021 Apr; 93(4):2115-2131. PubMed ID: 33091154
[TBL] [Abstract][Full Text] [Related]
22. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
[TBL] [Abstract][Full Text] [Related]
23. Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2.
Chakraborty C; Sharma AR; Bhattacharya M; Sharma G; Lee SS
Arch Med Res; 2021 May; 52(4):362-370. PubMed ID: 33546870
[TBL] [Abstract][Full Text] [Related]
24. Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.
Devi YD; Goswami HB; Konwar S; Doley C; Dolley A; Devi A; Chongtham C; Dowerah D; Biswa V; Jamir L; Kumar A; Satapathy SS; Ray SK; Deka RC; Doley R; Mandal M; Das S; Singh CS; Borah PP; Nath P; Namsa ND
PLoS One; 2021; 16(11):e0258645. PubMed ID: 34780495
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
[TBL] [Abstract][Full Text] [Related]
26. Design of a multi-epitope-based vaccine consisted of immunodominant epitopes of structural proteins of SARS-CoV-2 using immunoinformatics approach.
Mahmoudvand S; Esmaeili Gouvarchin Ghaleh H; Jalilian FA; Farzanehpour M; Dorostkar R
Biotechnol Appl Biochem; 2023 Jun; 70(3):1189-1205. PubMed ID: 36577011
[TBL] [Abstract][Full Text] [Related]
27. Identification of HLA-A*24:02-Restricted CTL Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 and Analysis of Their Conservation Using the Mutation Database of SARS-CoV-2 Variants.
Takagi A; Matsui M
Microbiol Spectr; 2021 Dec; 9(3):e0165921. PubMed ID: 34937174
[TBL] [Abstract][Full Text] [Related]
28. Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins.
Tajuelo A; López-Siles M; Más V; Pérez-Romero P; Aguado JM; Briz V; McConnell MJ; Martín-Galiano AJ; López D
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328398
[TBL] [Abstract][Full Text] [Related]
29. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
[TBL] [Abstract][Full Text] [Related]
30. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2.
Behmard E; Soleymani B; Najafi A; Barzegari E
Sci Rep; 2020 Nov; 10(1):20864. PubMed ID: 33257716
[TBL] [Abstract][Full Text] [Related]
31. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
32. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
[TBL] [Abstract][Full Text] [Related]
33. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.
Oyarzun P; Kashyap M; Fica V; Salas-Burgos A; Gonzalez-Galarza FF; McCabe A; Jones AR; Middleton D; Kobe B
Front Immunol; 2021; 12():598778. PubMed ID: 33717077
[TBL] [Abstract][Full Text] [Related]
34. Tracking the pipeline: immunoinformatics and the COVID-19 vaccine design.
Rezaei S; Sefidbakht Y; Uskoković V
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34219142
[TBL] [Abstract][Full Text] [Related]
35. Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2.
Rakib A; Sami SA; Islam MA; Ahmed S; Faiz FB; Khanam BH; Marma KKS; Rahman M; Uddin MMN; Nainu F; Emran TB; Simal-Gandara J
Molecules; 2020 Nov; 25(21):. PubMed ID: 33147821
[TBL] [Abstract][Full Text] [Related]
36. Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach.
Hisham Y; Ashhab Y; Hwang SH; Kim DE
Viruses; 2021 Apr; 13(5):. PubMed ID: 33925069
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
38. Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches.
Yu M; Zhu Y; Li Y; Chen Z; Li Z; Wang J; Li Z; Zhang F; Ding J
Front Immunol; 2022; 13():884433. PubMed ID: 35603198
[TBL] [Abstract][Full Text] [Related]
39. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
Ahmed SF; Quadeer AA; McKay MR
Viruses; 2020 Feb; 12(3):. PubMed ID: 32106567
[TBL] [Abstract][Full Text] [Related]
40. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
